-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
20, 2020 /--- new research shows that probiotics can control the development of colorectal cancer (CRC).
the study was recently published in the journal Microorganisms and was led by Dr Andrew Foey of the University of Pavol Jozef Safarik in Slovakia.
Foey and his team tested the ability of a mixture of lactic acid bacteria (LAB) strains to affect the activity of immune cells (macrophages) and the on the development of bowel cancer.
(Photo source: www.pixabay.com) showed that probiotic mixtures partially inhibited tumor occurrence and growth in CRC models.
researchers concluded that this may be due to the LAB mixture changing the way macrophages behave.
CRC is the country's fourth most common cancer, the second most common cancer killer, with more than 42,000 people diagnosed with the disease each year in the UK, according to the charity Bowel Cancer UK.
charity says one in 15 men and one in 18 women will be diagnosed with cancer in their lifetime.
Foey said: "This study focuses only on understanding CRC and potential treatments for controlling the disease.
study highlights the positive effects of probiotic mixtures on the CRC-related immune system and their implications for clinical translation studies.
this highlights the need for future research into probiotics for macrophage response therapy for colorectal cancer in the intestines.
also indicates the potential use of probiotics in the treatment of tissue-related cancers, such as oral squamous cell carcinoma.
(bioon.com) Source: Probiotics show to suppress growth of tumours in colorectal cancer Source: Petra Hradicka et al. A Novel Lactic Acid B. B. Partners: Macrophage-Targeted Prophylactic Intervention in ColorIngal Cancer Management, Microorganisms (2020). DOI: 10.3390/microorganisms8030387.